The Greater Zurich Area is a leading location for top biotech companies in Europe. The region attracts capital and researchers from across the globe. It is home to some of the most innovative businesses in the world. Key European biotechnology companies who chose Greater Zurich include Biogen, Benchlin, Johnson & Johnson, Apellis and Amgen.

Biotech companies in Greater Zurich can secure opportunities rarely seen in other places, e.g. from the flexible labor laws, a stable economic environment and a highly qualified workforce. Pharmaceutical companies receive the same benefits. The Greater Zurich Area truly is one of the finest biotech hubs in Europe.

It is no coincidence that the Greater Zurich Area is home to so many world-class patents for medical technology as nowhere else in Europe. Technology leaders such as Roche Diagnostics, Zimmer Biomet, Stryker, Hamilton, Sonova, Cardinal Health and DePuy Synthes (Johnson&Johnson) operate headquarters or research and production facilities here. They value the large pool of international specialists, the R&D collaborations with leading universities and start-ups, the protection of intellectual property and the business-friendly environment. Would your medtech company also like to write a success story in the Greater Zurich Area?